Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InnovAge Holding Corp. (INNV : NSDQ)

• Company Description    InnovAge Holding Corp. is a healthcare delivery platform. The Company delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors as well as it serve participants primarily through Program of All-inclusive Care for the Elderly. InnovAge Holding Corp. is based in DENVER, United States. Number of Employees: 2,440

• Price / Volume Information    Yesterday's Closing Price: $5.19 Daily Weekly Monthly 20 Day Moving Average: 146,431 shares Shares Outstanding: 135.68 (millions) Market Capitalization: $704.19 (millions) Beta: 0.57 52 Week High: $6.26 52 Week Low: $2.60 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.78% 0.95% 12 Week -12.63% -14.03% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8950 E. LOWRY BOULEVARD - DENVER,CO 80230 USA ph: 844-803-8745 fax: - rkubota@innovage.com http://www.innovage.com

• General Corporate Information    Officers Patrick Blair - Chief Executive Officer James Carlson - Chairman of the Board Benjamin C. Adams - Chief Financial Officer John Ellis Bush - Director Andrew Cavanna - Director Peer Information InnovAge Holding Corp. (CHCR) InnovAge Holding Corp. (ESRX) InnovAge Holding Corp. (MYDP) InnovAge Holding Corp. (COR) InnovAge Holding Corp. (GBCS) InnovAge Holding Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45784A104 SIC: 8000 Fiscal Year Fiscal Year End: June Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/03/26 Share - Related Items Shares Outstanding: 135.68 Most Recent Split Date: (:1) Beta: 0.57 Market Capitalization: $704.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.22 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/03/26

• Fundamental Ratios P/E Current FY Estimate: 23.59 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.82 Price/Cash Flow: - Price / Sales: 0.80 EPS Growth vs. Year Ago Period: 250.00% vs. Previous Quarter: 700.00% Sales Growth vs. Year Ago Period: 15.09% vs. Previous Quarter: 6.63% ROE 12/31/25 - - 09/30/25 - -7.02 06/30/25 - -12.02 ROA 12/31/25 - - 09/30/25 - -3.31 06/30/25 - -5.73 Current Ratio 12/31/25 - - 09/30/25 - 1.17 06/30/25 - 1.07 Quick Ratio 12/31/25 - - 09/30/25 - 1.17 06/30/25 - 1.07 Operating Margin 12/31/25 - - 09/30/25 - -1.96 06/30/25 - -3.55 Net Margin 12/31/25 - - 09/30/25 - -1.96 06/30/25 - -3.55 Pre-Tax Margin 12/31/25 - - 09/30/25 - -2.35 06/30/25 - -3.99 Book Value 12/31/25 - - 09/30/25 - 1.84 06/30/25 - 1.76 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.25 06/30/25 - 0.27 Debt-to-Capital 12/31/25 - - 09/30/25 - 26.14 06/30/25 - 27.45

Powered by Zacks Investment Research ©